Przegląd Dermatologiczny
facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
6/2024
vol. 111
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Opis przypadku

Juvenile Dermatomyositis Overlapping with Madelung Disease

Gabriela Rybka
1
,
Mariusz Korkosz
1, 2
,
Beata Machalica
3
,
Joanna Kosałka-Węgiel
1, 2

  1. Department of Rheumatology, Immunology and Internal Medicine, University Hospital, Krakow, Poland
  2. Department of Rheumatology and Immunology, Jagiellonian University Medical College, Krakow, Poland
  3. 2nd Department of Internal Medicine, University Hospital, Krakow, Poland
Dermatol Rev/Przegl Dermatol 2024, 111, 456-460
Data publikacji online: 2025/05/21
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Introduction:
Dermatomyositis belongs to the heterogeneous group of autoimmune inflammatory myopathies, whereas Madelung disease is a rare metabolic disorder characterized by symmetrical, non-encapsulated adipose tissue deposits.

Objective:
To the best of our knowledge, we present the first case in the literature with the coincidence of these two diseases.

Case report:
The patient was diagnosed with juvenile dermatomyositis at the age of 7 and was treated with steroids, azathioprine, and intravenous immunoglobulins. The diagnosis of Madelung disease was based on the physical examination and computed tomography scans when she was 42 years old. The patient declined surgical treatment for Madelung disease, and fibrate therapy did not provide any relief from her symptoms associated with the disease.

Conclusions:
We present the case of the coexistence of juvenile dermatomyositis, requiring long-term steroid therapy, with Madelung disease. Further research is needed to assess whether a diagnosis of juvenile dermatomyositis may increase the risk of developing Madelung disease.



© 2025 Termedia Sp. z o.o.
Developed by Bentus.